|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/73 | (2006.01) |
| C07D 213/73 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Patento numeris | 3935045 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20706521.0 |
| Europos patento paraiškos padavimo data | 2020-02-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-01-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-05-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2020/055292 |
| Data | 2020-02-28 |
| (87) | Numeris | WO 2020/178175 |
| Data | 2020-09-10 |
| (30) | Numeris | Data | Šalis |
| 19160904 | 2019-03-05 | EP |
| (72) |
PLATZEK, Johannes , DE
LOVIS, Kai , DE
|
| (73) |
Bayer Aktiengesellschaft ,
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen,
DE
Bayer Pharma Aktiengesellschaft , Müllerstrasse 178, 13353 Berlin, DE |
| (54) | SYNTHESE VON 4-AMINO-5-METHYL-1H-PYRIDIN-2(1H)-ON (ZWISCHENVERBINDUNG DER SYNTHESE DES MR ANTAGONSITEN FINERENONE) AUS 2-CHLORO-5-METHYL-4-NITRO-PYRIDINE-1-OXID ÜBER DIE ZWISCHENVERBINDUNG 2-CHLORO-5-METHYL-4-PYRIDINAMIN |
| SYNTHESIS OF 4-AMINO-5-METHYL-1H-PYRIDIN-2(1H)-ONE (INTERMEDIATE IN THE SYNTHESIS OF THE MR ANTAGONIST FINERENONE) FROM 2-CHLORO-5-METHYL-4-PYRIDINAMINE VIA THE INTERMEDIATE 2-CHLORO-5-METHYL-4-PYRIDINEAMINE |